Ischemic-Modified Albumin in Neonates with Congenital Heart Defects.

Didem G KorkutFerda OzlüGülizar AtlıŞule M YıldızFadli DemirUğur GöçenHacer Yapıcıoğlu

Published in: American journal of perinatology (2022)

· IMA is a new biochemical marker of ischemia.. · In the literature, there are no reports about the relation between congenital heart defects and IM.. · The exposure of CHD patients to hypoxia/asphyxia in the preintra and postoperative periods cause neurologic deficits.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
patients undergoing
peritoneal dialysis
endothelial cells
patient reported outcomes
preterm birth
electronic health record